Cambridge Bioscience Named Exclusive Distributor for NanoInk in UK, Ireland | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoInk today announced that Cambridge Bioscience will exclusively distribute its desktop nanofabrication equipment in the UK and Ireland.

The deal includes NanoInk's NLP 2000 System and DPN 5000 System.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.